Sintilimab, Pegaspargase Plus GemOx for Untreated Extranodal NK/T-Cell Lymphoma

Clinical trial NCT06824883 · RECRUITING

Trial details

NCT number: NCT06824883
Sponsor: Peking Union Medical College Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Extranodal NK/T-cell Lymphoma

Start date: 2024-05-20
Primary completion: 2026-05-20
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.